| 摘要 |
<p>Provided are methods for the diagnosis and treatment of acute myelogenous leukemia. In particular, the present invention relates to the use of Trib2 polynucleotides and polypeptides for the diagnosis and treatment of acute myelogenous leukemia (AML) by assessing myeloid cells of a patient, or malignancies associated with Trib2, C/EBPap30 or C/EBPap42, such as AML or lung cancer, by assessing hematopoietic stem cells of the patient.</p> |
| 申请人 |
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA;PEAR, WARREN, S.;KEESHAN, KAREN;HE, YIPING |
发明人 |
PEAR, WARREN, S.;KEESHAN, KAREN;HE, YIPING |
